Boehringer Ingelheim Opens Global Center for Veterinary Vaccine Development
Boehringer Ingelheim opened its $81 million global center for veterinary vaccine development in October of 2018. Located in Lyon, France, the four-story, 156,000-sf facility provides research and development laboratories for the creation of animal vaccines for diseases such as rabies and avian influenza. Designed as an international center for biological excellence, the project features scalable production suites and can accommodate 200 employees.